Virginija Sukaitiene

Virginija Sukaitiene has extensive experience in the pharmaceutical industry, primarily in medical review roles related to cell therapy, hematology, and hemato-oncology. Currently serving as Senior Director and Therapeutic Area Head for Cell Therapy at Bristol Myers Squibb, Virginija has also held similar positions at Celgene, where responsibilities included directing medical review activities. Earlier in the career at AstraZeneca Pharmaceuticals, Virginija worked as a Medical Coordinator and Medical Representative. Virginija completed a Doctor of Medicine degree at Vilnius University from 1983 to 1990 and attended Klaipedos Azuolyno gimnazija from 1979 to 1982.